For Physicians
California Pacific Medical Center's Liver Disease Management and Transplant team is available to assist with your complex case patients. Read about our referral process for further details. We have 12 outreach clinics in Northern California and Nevada that we visit to evaluate and monitor patients with liver disease. We also lecture locally and internationally and have online information and tools to provide further information about liver disease and transplantation.
Outreach Clinic Schedule and download our Referral Form (.doc file)
Visiting GI Scholar Program at California Pacific Medical Center: Northern California and Nevada gastroenterologists are welcome to participate in our monthly program that offers an "insider" view of our liver disease and complex gastroenterology programs.
Continuing Education: Advanced Certificate Program IV: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities. Adrian M. Di Bisceglie, MD, FACP, and Robert G. Gish, MD, co-chair this free, yearlong CME/CE program featuring the very latest information on screening and current and emerging treatment strategies for HBV management, including new guidelines from the CDC, AASLD, and Keeffe. Courses are released continuously throughout the year, and all offer CME and CE credit. Learn more and enroll!
Recent articles authored by our physicians include:
- Frenette C, Gish R, Review of Selected Liver Cancer Abstracts from the AASLD Meeting in SF 2008 for NATAP. AASLD Nov. 2008.
- Block TM, Marrero J, Gish RG, Sherman M, London WT, Srivastava S, Wagner PD. The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop. Cancer Biomark. 2008;4(1):19-33. Review.
- Xu L, Guo L, Shen Z, Loss G, Gish R, Wasilenko S, Mason AL. Duplication of MER115 on chromosome 4 in patients with primary biliary cirrhosis. Liver Int. 2008 Oct 10.
- Veenstra DL, Spackman DE, Di Bisceglie A, Kowdley KV, Gish RG. Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effective analysis. Aliment Pharmacol Ther. 2008 Jun;27(12):1240-52. Epub 2008 Mar 27. Review.
- Gish RG, Baron A. Hepatocellular carcinoma (HCC): current and evolving therapies. IDrugs. 2008 Mar;11(3):198-203. Review.
- Gish R, Marrero JB, Tong MJ. Medical therapies to extend survival in hepatocellular carcinoma. Clin Adv Hematol Oncol. 2008 Aug;6(8):1-14; quiz 15.
- Gastroenterology: Entecavir Therapy for Patients with HBeAg-Positive Chronic Hepatitis B
- Journal of Viral Hepatitis: Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection. (pdf file)
California Pacific is at the forefront of advances and research. The liver team conducts multiple using new, ground-breaking medications in the areas of viral hepatitis, liver cancer and liver transplantation, and recruits patients from Northern California and Nevada.
Liver Disease and Transplant Info. & Tools
Access our handouts on more than 30 liver disease topics including hepatitis C and fatty liver. Our clinical pathways and disease guidelines include:
- Hepatitis C Clinical Pathway (pdf file)
- Liver Biopsy Clinical Pathway
- Liver Biopsy Management Guideline Protocol (pdf file)
Read our semi-annualLiver & GI Review newsletter with information on research trials, surgical techniques, liver disease and updates about California Pacific's Liver Disease Management and Transplant Program.
Speaker's Bureau
Review topics our hepatologists have presented or request more information about our speaker's bureau.